Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income $ 80,310 $ 59,621 $ 58,563
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 131,646 132,640 124,551
Amortization 50,444 52,594 52,589
Amortization of inventory step-up 0 1,603 871
Intangible asset impairment charge 1,600 0 0
Amortization of deferred financing costs and original issue discount 5,777 6,119 8,733
Debt extinguishment costs 3,400 5,627 61,362
Foreign currency exchange loss 2,787 13,810 25,786
Pension and postretirement healthcare benefit expense 3,702 1,073 3,289
Pension and postretirement healthcare benefit funding (9,670) (7,602) (7,887)
Deferred income tax provision (benefit) 18,308 3,445 (140,212)
Net (gain) loss on asset disposals (13,068) 6,574 5,793
Stock compensation 18,225 19,464 8,799
Equity in net income from affiliated companies (46,034) (37,611) (38,772)
Dividends received from affiliated companies 40,123 40,195 44,071
Net interest income on swaps designated as net investment hedges (8,480) (4,859) 0
Gain on contract termination 0 (20,612) 0
Other, net (6,330) (1,517) (4,061)
Working capital changes that provided (used) cash, excluding the effect of acquisitions and dispositions:      
Receivables 14,538 (10,451) (11,463)
Inventories (18,943) (8,980) (21,200)
Prepaids and other current assets 1,256 (6,348) (3,434)
Accounts payable (2,308) (146) 4,343
Accrued liabilities 480 4,005 (6,548)
Net cash provided by operating activities 267,763 248,644 165,173
Cash flows from investing activities:      
Purchases of property, plant and equipment (127,642) (131,688) (140,482)
Investment in affiliated companies 0 (5,000) (9,000)
Loan receivable under the New Markets Tax Credit Arrangement 0 0 (6,221)
Business combinations, net of cash acquired 0 (1,006) (41,572)
Proceeds from sale of assets 17,600 12,380 0
Proceeds from sale of product line 27,658 0 0
Proceeds from settlement of swaps designated as net investment hedges 38,070 0 0
Net interest proceeds on swaps designated as net investment hedges 8,480 4,859 0
Other, net 475 1,165 1,293
Net cash used in investing activities (35,359) (119,290) (195,982)
Cash flows from financing activities:      
Draw down of revolving credit facilities 203,542 141,764 357,773
Repayments of revolving credit facilities (202,802) (166,778) (334,180)
Issuance of long-term debt 0 1,267,000 308,550
Debt issuance costs 0 (6,395) (4,666)
Repayments of long-term debt (216,659) (1,369,690) (739,472)
Debt prepayment fees 0 0 (47,875)
IPO proceeds 0 0 507,500
IPO costs 0 0 (26,804)
Repurchases of common shares (3,563) (2,920) 0
Proceeds from stock options exercised 3,975 131 0
Other, net (586) (337) (993)
Net cash (used in) provided by financing activities (216,093) (137,225) 19,833
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2,120) 354 (6,858)
Net change in cash, cash equivalents and restricted cash 14,191 (7,517) (17,834)
Cash, cash equivalents and restricted cash at beginning of period 59,726 67,243 85,077
Cash, cash equivalents and restricted cash at end of period $ 73,917 $ 59,726 $ 67,243